drugset / Trial / NCT06696625

Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye

NCT06696625

Recruiting 256 enrolled Beijing Tongren Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease. Methods: The investigators enrolled 256 patients at Beijing Tongren Hospital. Patients completed questionnaires at baseline, 1 month, 3 months, and 6 months. OSDI score, TBUT, Schirmer I, CFS, SF36, DEQ5, and psychological status to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.

Timeline

Start
2021-07-01
Primary completion
2025-11-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Background Sodium Hyaluronate Other / unclassified 0.1 % Other

Indications